Rhesus Disease
Showing 1 - 25 of >10,000
Rhesus Isoimmunization Trial in Banha (Delayed cord clamping, Early cord clamping)
Recruiting
- Rhesus Isoimmunization
- Delayed cord clamping
- Early cord clamping
-
Banhā, Qalubia, EgyptBenha University Hospital
Mar 4, 2022
The Prevention of Rh Disease of Newborns in Pakistan
Completed
- Rhesus Disease
- Anti-D (Rh) Antibodies Affecting Care of Mother
- RhIg prophylaxis
- +2 more
-
Dādu, Sindh, PakistanTaluka Headquarter Hospital Johi and District Headquarter Hospit
Jul 8, 2020
Hemolytic Disease of the Fetus and Newborn Trial in Worldwide (M281)
Active, not recruiting
- Hemolytic Disease of the Fetus and Newborn
-
San Francisco, California
- +18 more
Jan 17, 2023
Erythroblastosis, Fetal, Erythroblastosis Fetalis, Rh Disease, Erythroblastosis Fetalis Due to RH Antibodies Trial in Leiden
Unknown status
- Erythroblastosis, Fetal
- +3 more
- Darbepoetin Alfa
-
Leiden, NetherlandsLeiden University Medical Center
Sep 30, 2019
ABO Blood Group Type Association With COVID-19 Severity
Completed
- COVID-19
- +4 more
- No Intervention
-
Colton, CaliforniaArrowhead Regional Medical Center
May 15, 2023
Pregnancy Related Trial in Ukraine (Human Anti-D (rh) immunoglobulin)
Recruiting
- Pregnancy Related
- Human Anti-D (rh) immunoglobulin
-
Cherkasy, Cherkasy Region, Ukraine
- +15 more
Jun 23, 2022
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
HIV Trial (gp160 MN/LAI-2, Aluminum hydroxide)
Completed
- HIV Infections
- gp160 MN/LAI-2
- Aluminum hydroxide
- (no location specified)
Oct 13, 2021
Acute Respiratory Distress Syndrome Trial (Human Umbilical Cord Mesenchymal Stem Cells)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Human Umbilical Cord Mesenchymal Stem Cells
- (no location specified)
Aug 7, 2023
Neonatal Cord Blood Screening for HDN
Not yet recruiting
- HDN - Hemolytic Disease of the Newborn
- (no location specified)
Nov 8, 2022
Development of Non-Invasive Prenatal Diagnosis for Single Gene
Not yet recruiting
- Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including
- +14 more
- Blood sample
-
Paris, FranceHôpital Cochin, Maternité Port-Royal, service de Gynécologie obs
Nov 24, 2023
Study of Multidrug-Resistant Patient Outcomes With and Without
Recruiting
- HIV Infections
- Multi-Antiviral Resistance
- No ibalizumab or Pre-ibalizumab treatment
- On ibalizumab treatment
-
Los Angeles, California
- +38 more
Jan 31, 2023
Fasting Trial in Sacramento (Dietary Fasting)
Recruiting
- Fasting
- Dietary Fasting
-
Sacramento, CaliforniaUC Davis
May 10, 2022
Overweight and Obesity, Time Restricted Feeding, Alzheimer Trial (Time Restricted Eating intervention, Successful Aging
Not yet recruiting
- Overweight and Obesity
- +2 more
- Time Restricted Eating intervention
- Successful Aging Comparison Group (LEARN)
- (no location specified)
Feb 17, 2023
Following SARS-CoV-2 (Covid-19) Vaccinations
Recruiting
- Covid-19
- Subjects Vaccinated Against Covid-19
- Change in SARS-CoV-2 Antibody Levels
-
Southlake, TexasSouthlake Diagnostics, Inc.
Aug 26, 2022
Neonatal Jaundice Trial in Tangail (Home based phototherapy and referral)
Recruiting
- Neonatal Jaundice
- Home based phototherapy and referral
-
Tangail, Dhaka, BangladeshMirzapur
Mar 29, 2022
Covid19 Trial in Dhaka (Remdesivir, Standard of Care)
Completed
- Covid19
- Remdesivir
- Standard of Care
-
Dhaka, BangladeshCombined Military Hospital
Aug 9, 2021
Artery; Dilatation Trial (Nitroglycerin ointment)
Not yet recruiting
- Artery; Dilatation
- Nitroglycerin ointment
- (no location specified)
Mar 28, 2022
HIV, Human Immunodeficiency Virus Trial in Salt Lake City (Euphorbia kansui extract powder prepared as tea)
Suspended
- HIV
- Human Immunodeficiency Virus
- Euphorbia kansui extract powder prepared as tea
-
Salt Lake City, UtahUniversity of Utah
Mar 22, 2022
Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,
Recruiting
- Idiopathic Parkinson's Disease
- PD patients H&Y=1.5-2 Medications ON
- +4 more
-
Pozzilli, Isernia, ItalyIRCSS Neuromed Hospital
May 18, 2022
Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in
Recruiting
- Other Disorders of Vestibular Function, Bilateral
- +5 more
- Labyrinth Devices MVI™ Multichannel Vestibular Implant
-
Baltimore, MarylandJohns Hopkins School of Medicine
Aug 31, 2021
Kleihauer in Patients With Decreased Active Fetal Movements
Active, not recruiting
- Fetal Movement Disorder
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Jun 29, 2022
Coronavirus Disease 2019 (COVID-19) Trial in United States (CD24Fc, Placebo)
Completed
- Coronavirus Disease 2019 (COVID-19)
- CD24Fc
- Placebo
-
Jacksonville, Florida
- +9 more
Oct 13, 2021
Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Trial in New York (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies,
Completed
- Batten Disease
- Late-Infantile Neuronal Ceroid Lipofuscinosis
- AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies
- AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies
-
New York, New YorkWeill Cornell Medical College
Jan 31, 2021
Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)
Recruiting
- Adamantinomatous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
-
Aurora, Colorado
- +17 more
Jan 8, 2023